Detalhe da pesquisa
1.
Use of sodium-glucose cotransporter-2 inhibitors in France: Analysis of French nationwide health insurance database.
Diabetes Obes Metab
; 26(5): 1678-1686, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38288619
2.
Cholangitis Induced by Immune Checkpoint Inhibitors: Analysis of Pharmacovigilance Data.
Clin Gastroenterol Hepatol
; 2023 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38110061
3.
Comprehensive description of adult-onset Still's disease after COVID-19 vaccination.
J Autoimmun
; 134: 102980, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36592513
4.
Incidence and preventability of hospital admissions for adverse drug reactions in France: A prospective observational study (IATROSTAT).
Br J Clin Pharmacol
; 89(1): 390-400, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36002314
5.
Pulmonary hypertension reported with immune checkpoint inhibitors: a pharmacovigilance study.
Cancer Immunol Immunother
; 71(12): 3093-3097, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35616698
6.
Dementia Associated with Anticholinergic Drugs Used for Overactive Bladder: A Nested Case-Control Study Using the French National Medical-Administrative Database.
J Urol
; 208(4): 863-871, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35686842
7.
Adverse reactions with levamisole vary according to its indications and misuse: A systematic pharmacovigilance study.
Br J Clin Pharmacol
; 88(3): 1094-1106, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34390273
8.
Impact of the COVID-19 pandemic and its control measures on cardiovascular and antidiabetic drugs use in France in 2020: a nationwide repeated cohort study.
Eur J Epidemiol
; 37(10): 1049-1059, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36129659
9.
Drug-induced osteoporosis/osteomalacia: analysis in the French and Spanish pharmacovigilance databases.
Eur J Clin Pharmacol
; 75(12): 1705-1711, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31468068
10.
[Case-non case studies: Principles, methods, bias and interpretation]. / Les études casnon cas : principe, méthodes, biais et interprétations.
Therapie
; 73(3): 247-255, 2018.
Artigo
em Francês
| MEDLINE | ID: mdl-29174397
11.
Nicorandil-induced ulcerations: a 10-year observational study of all cases spontaneously reported to the French pharmacovigilance network.
Int Wound J
; 15(4): 508-518, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29767853
12.
Rheumatic disorders associated with immune checkpoint inhibitors: what about myositis? An analysis of the WHO's adverse drug reactions database.
Ann Rheum Dis
; 81(2): e32, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32066555
13.
Pharmacological aspects of the safety of gliflozins.
Pharmacol Res
; 118: 71-81, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27389050
14.
Monitoring of patients with systemic lupus erythematosus during the COVID-19 outbreak.
Ann Rheum Dis
; 80(4): e56, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32513650
15.
Pharmacoepidemiology and its input to pharmacovigilance.
Therapie
; 71(2): 211-6, 2016 Apr.
Artigo
em Inglês, Francês
| MEDLINE | ID: mdl-27080840
16.
[Immortal time bias in pharmacoepidemiological studies: definition, solutions and examples]. / Le biais de temps immortel dans les études pharmacoépidémiologiques : définition, solutions et exemples.
Therapie
; 70(3): 259-63, 2015.
Artigo
em Francês
| MEDLINE | ID: mdl-25487848
17.
Screening patients at risk for diabetic foot ulceration: a comparison between measurement of vibration perception threshold and 10-g monofilament test.
Int Wound J
; 11(2): 147-51, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22892021
18.
Drug-induced hyperglycemia and diabetes.
Therapie
; 79(2): 221-238, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37985310
19.
The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration.
Drug Saf
; 47(6): 585-599, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38713347
20.
The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement.
Drug Saf
; 47(6): 575-584, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38713346